Metraipolis › archive › dc_6ae6bd3e73fa
Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis — Europe PMC PMID:41732608
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41732608
- DOI
- 10.7759/cureus.102134
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:12:45.371Z
- SHA-256 of the archived text
c46efa7ba456c816b468bf1092cd60a9a80eda142d8c9bdddba052eb20cd7de0- Stable URL of this page
https://metraipolis.com/documento/dc_6ae6bd3e73fa
How to cite
Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis — Europe PMC PMID:41732608 — Europe PMC (en), https://europepmc.org/article/MED/41732608 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ae6bd3e73fa (Metraipolis archive dc_6ae6bd3e73fa, sha256 c46efa7ba456c816b468bf1092cd60a9a80eda142d8c9bdddba052eb20cd7de0)
BibTeX
@misc{dc6ae6bd3e73fa,
title = {Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis — Europe PMC PMID:41732608},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41732608},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ae6bd3e73fa; sha256 c46efa7ba456c816b468bf1092cd60a9a80eda142d8c9bdddba052eb20cd7de0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41732608. Agents can read the archived copy with the MCP tool read_document.